Paul C. Shellito

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

Christopher G. Willett, Yves Boucher, Emmanuelle di Tomaso et al. · Nature Medicine · 2004 · 1.9K citations · Full text

Angiogenesis, Medicine, Human Rectal Cancer +9

Practice Parameters for Sigmoid Diverticulitis

Janice F. Rafferty, Paul C. Shellito, Neil Hyman et al. · Diseases of the Colon & Rectum · 2006 · 698 citations

Surgical Oncology, Standards Committee, Colorectal Surgery +9

Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study

Christopher G. Willett, Dan G. Duda, Emmanuelle di Tomaso et al. · Journal of Clinical Oncology · 2009 · 503 citations · Full text

Practice Parameters for the Treatment of Perianal Abscess and Fistula-in-Ano (Revised)

Mark H. Whiteford, John Kilkenny, Neil Hyman et al. · Diseases of the Colon & Rectum · 2005 · 369 citations

Rectal Surgery, Rectal Surgeons, Colorectal Surgery +11

Prognostic factors in Stage T2NO rectal cancer

Christopher G. Willett, Kamran Badizadegan, Marek Ancukiewicz et al. · Diseases of the Colon & Rectum · 1999 · 267 citations